Otonomy s Ear Infection Drug Succeeds In Late-stage Trial

Jan 5 (Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection in the outer ear canal, vtr.org.vn met the main goal in a late-stage trial.

The drug, tour đài loan từ hà nội Otiprio, tour đài loan từ hà nội is approved for use in pediatric patients during tympanostomy tube placement surgery.

The company said it would submit a supplemental marketing approval application with the U.S. Food and Drug Administration in the first half of 2017. (Reporting by Divya Grover in Bengaluru; Editing by Shounak Dasgupta)